Q3 2024 · 13F-HR
Altium Capital Management LLCholdings as filed
Filed 2024-11-14 · accession 0001420506-24-002530
$339.7M
Reported value
79
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92337R101 | VERA | VERA THERAPEUTICS INC | $30.2M | 8.90% | 684,000 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $27.2M | 8.00% | 1,360,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $21.2M | 6.25% | 170,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $14.6M | 4.31% | 222,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $14.2M | 4.18% | 360,600 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $11.8M | 3.47% | 1,700,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $11.3M | 3.32% | 154,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $10.7M | 3.16% | 212,909 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $10.0M | 2.95% | 77,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $9.5M | 2.79% | 130,000 | Common | SOLE |
| 589889104 | MMSI | MERIT MED SYS INC | $8.4M | 2.47% | 85,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $8.2M | 2.43% | 1,700,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $8.2M | 2.42% | 72,000 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $8.0M | 2.36% | 610,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $8.0M | 2.35% | 126,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $7.7M | 2.25% | 385,000 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $7.1M | 2.08% | 369,126 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $6.9M | 2.02% | 355,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $6.7M | 1.97% | 1,575,000 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $6.4M | 1.88% | 86,000 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $5.8M | 1.69% | 355,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $5.7M | 1.67% | 131,000 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $5.5M | 1.63% | 112,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $5.2M | 1.53% | 58,000 | Common | SOLE |
| 83086J200 | SKYE | SKYE BIOSCIENCE INC | $5.1M | 1.51% | 1,315,146 | Common | SOLE |
| 98420P308 | XTNT | XTANT MED HLDGS INC | $5.0M | 1.48% | 7,415,413 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $4.5M | 1.34% | 693,000 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $4.3M | 1.28% | 285,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $4.1M | 1.22% | 500,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $4.0M | 1.18% | 195,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $4.0M | 1.18% | 69,000 | Common | SOLE |
| 88339P101 | REAL | THE REALREAL INC | $4.0M | 1.17% | 1,270,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $3.9M | 1.14% | 290,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $3.7M | 1.10% | 75,000 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $3.6M | 1.07% | 355,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $3.1M | 0.90% | 70,000 | Common | SOLE |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $2.9M | 0.85% | 541,549 | Common | SOLE |
| 92346J108 | VCEL | VERICEL CORP | $2.9M | 0.85% | 68,000 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $2.8M | 0.83% | 317,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.8M | 0.81% | 330,000 | Common | SOLE |
| 67577C105 | OCGN | OCUGEN INC | $2.3M | 0.69% | 2,350,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $2.0M | 0.59% | 40,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $1.9M | 0.57% | 85,000 | Common | SOLE |
| 03615A108 | ANVS | ANNOVIS BIO INC | $1.9M | 0.56% | 236,400 | PUT | SOLE |
| 92536C103 | VERUEUR | VERU INC | $1.6M | 0.46% | 2,028,534 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $1.5M | 0.45% | 54,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $1.3M | 0.38% | 196,000 | CALL | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $1.1M | 0.32% | 915,000 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $802,771 | 0.24% | 238,920 | Common | SOLE |
| 87978U108 | OVASUSD | TEMPEST THERAPEUTICS INC | $763,000 | 0.22% | 545,000 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $726,744 | 0.21% | 581,395 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $668,800 | 0.20% | 440,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $614,200 | 0.18% | 740,000 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $600,837 | 0.18% | 1,473,000 | Common | SOLE |
| 30258N121 | FATBW | FAT BRANDS INC | $499,000 | 0.15% | 200,000 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $476,850 | 0.14% | 56,100 | PUT | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $460,100 | 0.14% | 215,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $370,078 | 0.11% | 9,400 | CALL | SOLE |
| 08771Y402 | SRXH | BETTER CHOICE CO INC | $278,215 | 0.08% | 133,117 | Common | SOLE |
| 30218B100 | — | EXPION360 INC | $106,372 | 0.03% | 2,057,494 | Common | SOLE |
| 65344E115 | NXGLW | NEXGEL INC | $91,474 | 0.03% | 225,000 | Common | SOLE |
| 42237K508 | SCPX | SCORPIUS HOLDINGS INC | $63,570 | 0.02% | 88,291 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $51,209 | 0.02% | 731,561 | Common | SOLE |
| 68277K124 | ONFOW | ONFOLIO HOLDINGS INC | $34,000 | 0.01% | 200,000 | Common | SOLE |
| M97838110 | WLDSW | WEARABLE DEVICES LTD | $28,091 | 0.01% | 1,411,600 | Common | SOLE |
| 60743G118 | MOBXW | MOBIX LABS INC | $22,320 | 0.01% | 150,000 | Common | SOLE |
| 17248W113 | CINGW | CINGULATE INC | $18,684 | 0.01% | 270,000 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $14,845 | 0.00% | 11,419 | Common | SOLE |
| 65345B110 | NXLIW | NEXALIN TECHNOLOGY INC | $8,400 | 0.00% | 105,000 | Common | SOLE |
| 86887P119 | BNCWW | CEA INDUSTRIES INC | $6,275 | 0.00% | 250,000 | Common | SOLE |
| 92919Y110 | VSEEW | VSEE HEALTH INC | $6,000 | 0.00% | 150,000 | Common | SOLE |
| 09174P113 | BTMWW | BITCOIN DEPOT INC | $2,495 | 0.00% | 50,000 | Common | SOLE |
| M61472110 | NEXRW | JEFFS BRANDS LTD | $2,445 | 0.00% | 68,681 | Common | SOLE |
| H57830111 | — | NLS PHARMACEUTICS LTD | $2,280 | 0.00% | 200,000 | Common | SOLE |
| 95758L115 | CYCUW | WESTERN ACQSTN VENTURES CORP | $2,180 | 0.00% | 100,000 | Common | SOLE |
| 20678X114 | CDTTW | CONDUIT PHARMACEUTICALS INC | $1,595 | 0.00% | 100,000 | Common | SOLE |
| G2263T107 | — | COLISEUM ACQUISITION CORP | $1,417 | 0.00% | 28,333 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $1,044 | 0.00% | 82,233 | Common | SOLE |
| 87807D111 | TCBWF | TC BIOPHARM HOLDINGS PLC | $343 | 0.00% | 18,823 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.